Ligandal
Developer of nanomedicine therapies designed to offer gene editing tools with non-viral nano-carriers to treat gene-related diseases. The company's therapies include peptide-based technologies for gen...
Valuation
$0
Share Price
N/A
Total Raised
$9.2M
Last Round
N/A